The Health Sciences Authority (HSA) would like to update on the new restrictions on the use of metoclopramide-containing products in order to reduce the risk of neurological and other dose-related adverse reactions.
Member’s Login
Membership Renewal
Calling all PSS members: Have you renewed your membership yet?
Click on Instructions for payment modes to renew
E-Bulletins
Choose an issue :
118th PSS annual general meeting
We are...
